Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 290 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Toxicity/Benefit Ratio Optimization of Chemotherapy in Colorectal Cancer (CRC) Patients by Determination of Individual Genotypic Determinants

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Diagnostic, Treatment				Active				18 to 85				Other				COLOGEN NCT00138060


2.		p53-Adjusted Neoadjuvant Chemotherapy for Potentially Resectable Esophageal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Biomarker/Laboratory analysis, Treatment				Active				18 to 75				Other				ASSO OE-1 EudraCT 2006-006647-31, NCT00525200

First Published: 11/14/2007


3.		Phase IV Study of Chemoresistance Markers in Patients Undergoing Chemotherapy for Metastatic Colorectal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Biomarker/Laboratory analysis, Treatment				Active				18 and over				Other				CHUL-BIO-COLON RECF0356, INCA-RECF0356, NCT00559676


4.		A Clinical Trial of a Radiation Sensitizer in Radiochemotherapy for Thoracic Esophageal Squamous Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Treatment				Active				18 to 70				Pharmaceutical / Industry				CMNa-ESO-01-2007 NCT00642239


5.		Yunzhi as Dietary Supplement in Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Treatment				Active				18 and over				Other				YUNZHI-BC NCT00647075

Last Modified: 6/15/2007 First Published: 5/23/2005


6.		Phase II/III Randomized Study of Oxaliplatin, Irinotecan, Leucovorin Calcium, and Fluorouracil Versus Gemcitabine as First-Line Chemotherapy in Patients With Metastatic Adenocarcinoma of the Pancreas

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Active				18 to 75				Other				FRE-FNCLCC-ACCORD-11/0402 EU-20512, NCT00112658

Last Modified: 2/15/2007 First Published: 3/13/2006


7.		Phase II/III Randomized Study of Fluorouracil, Cisplatin, and Radiotherapy Versus Gemcitabine Hydrochloride and Oxaliplatin in Patients With Unresectable, Nonmetastatic Cancer of the Biliary Tract

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Active				18 and over				Other, Pharmaceutical / Industry				FFCD-9902 SANOFI-FFCD-9902, LILLY-FFCD-9902, FFCD-FNCLCC-SFRO-9902, NCT00304135


8.		First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Active				18 and over				Pharmaceutical / Industry				D8480C00013 Eudract Number 2005-003440-66, NCT00384176


9.		FOLFOX Plus SIR-SPHERES MICROSPHERES Versus FOLFOX Alone in Patients With Liver Mets From Primary Colorectal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Active				18 and over				Pharmaceutical / Industry				STX0206 NCT00724503


10.		FOLFOX6 Plus Sir-Spheres Microspheres Plus Avastin in Patients With Nonresectable Liver Metastases From Colorectal Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Active				18 and over				Pharmaceutical / Industry				STX0207 NCT00735241

Select All on One Page


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute